MADISON HEIGHTS, Mich.,
Feb. 7, 2018 /PRNewswire/
-- InfuSystem Holdings, Inc. (NYSE American: INFU)
("InfuSystem" or the "Company"), a leading national provider of
infusion pumps and related services for the healthcare industry in
the United States and Canada, today announced that its interim chief
financial officer, Christopher
Downs, has informed the Company of his decision to resign
his position with the Company, effective March 31, 2018. Mr. Downs resignation does
not reflect any dispute or disagreement with the Company, nor does
it relate to any issues with respect to the Company's financial
performance.
Mr. Downs has agreed to continue in his position as interim
chief financial officer until the end of the current quarter in
order to assist the Company with the preparation and reporting of
its annual financial statements. Following Mr. Downs's
departure, Trent Smith, CPA,
InfuSystem's executive vice president, corporate controller and
chief accounting officer will assume Mr. Downs's responsibilities
as treasurer and principal financial officer. The Company will
immediately begin a search for a new chief financial officer.
Richard DiIorio, president and
chief executive officer, said, "I want to thank Chris for his
service to the Company over the past six years and especially since
August of 2016 when he took over the reins as interim CFO. We
understand Chris' decision, and everyone at InfuSystem wishes the
best for him and his family. Chris has been very gracious in
agreeing to continue with the Company through the end of the
quarter to facilitate an orderly transition and to assist in
preparing the financial reporting for the just completed fiscal
year. We have commenced a search and hope to have a new CFO in
place shortly after Chris' scheduled departure."
"Looking ahead, I am excited about our outlook for 2018, as we
continue to gain traction on our strategic initiatives to more
efficiently manage our business for improved financial
performance," concluded Mr. DiIorio.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion
pumps and related services to hospitals, oncology practices and
other alternate site healthcare providers. Headquartered in
Madison Heights, Michigan, the
Company delivers local, field-based customer support and also
operates Centers of Excellence in Michigan, Kansas, California, Texas, Georgia and Ontario, Canada. The Company's stock is
traded on the NYSE American under the symbol INFU.
Forward-Looking Statements
Statements made in this press release that are not
historical facts are considered to be forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as
amended (the "Securities Act") and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"). The words
"believe," "may," "will," "estimate," "continue," "anticipate,"
"intend," "should," "plan," "expect," "strategy," "future,"
"likely," variations of such words, and other similar expressions,
as they relate to the Company, are intended to identify
forward-looking statements. However, the absence of these words or
similar expressions does not mean that a statement is not
forward-looking. Forward-looking statements include statements
relating to future actions, business plans, objectives and
prospects, future operating or financial performance. In connection
with the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995, the Company is identifying certain
factors that could cause actual results to differ, perhaps
materially, from those indicated by these forward-looking
statements. Those factors, risks and uncertainties include, but are
not limited to, potential changes in overall healthcare
reimbursement, including CMS competitive bidding, sequestration,
concentration of customers, increased focus on early detection of
cancer, competitive treatments, dependency on Medicare Supplier
Number, availability of chemotherapy drugs, global financial
conditions, changes and enforcement of state and federal laws,
natural forces, competition, dependency on suppliers, risks in
acquisitions & joint ventures, U.S. Healthcare Reform,
relationships with healthcare professionals and organizations,
technological changes related to infusion therapy, dependency on
websites and intellectual property, the ability of the Company to
successfully integrate acquired businesses, dependency on key
personnel, dependency on banking relations and covenants, and other
risks associated with our common stock, as well as any litigation
to which the Company may be involved in from time to time; and
other risk factors as discussed in the Company's annual report on
Form 10-K for the year ended December 31,
2016 and in other filings made by the Company from time to
time with the Securities and Exchange Commission, including our
quarterly reports on Form 10-Q. Our annual report on Form 10-K is
available on the SEC's EDGAR website at www.sec.gov, and a copy may
also be obtained by contacting the Company. All forward-looking
statements made in this press release speak only as of the date
hereof. We do not intend, and do not undertake any obligation, to
update any forward-looking statements to reflect future events or
circumstances after the date of such statements, except as required
by law.
Additional information about InfuSystem Holdings, Inc. is
available at www.infusystem.com.
CONTACT:
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
Lytham Partners,
LLC
|
|
602-889-9700
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/infusystem-holdings-inc-reports-interim-chief-financial-officer-will-leave-company-at-end-of-current-quarter-300595322.html
SOURCE InfuSystem Holdings, Inc.